Tuberculosis is a global burden with oneâthird of the worldâs population infected with the pathogen Mycobacterium tuberculosis complex and an annual 1.4 million deaths from the disease. This high incidence of infection and the increased rate of multi-drug resistant and extensively-drug resistant strains of the organism further complicated the problem of TB control and have called for an urgent need to develop new anti-TB drugs from plants. OMICS Group International is an open access publisher and scientific event organizer. OMICS Group publishes 700+ peer-reviewed journals with the support of about 25000 editorial board members.
Last date updated on April, 2024